Sunderstorm, a California-based leader in premium cannabis products and owner of the KANHA brand, today announced a strategic partnership with New Garden Pharma, a licensed manufacturer in North Macedonia, to further expand its global footprint into Europe and Australia.
Sunderstorm is also working with other global partners, including California's Medical GmbH in Germany, FuGu Holdings in Australia, and Grow Group UK in the United Kingdom. The partnerships mark the next phase of Sunderstorm's long-term global strategy, focusing on entry into the global medical-grade cannabis market.
Founded in California 10 years ago, KANHA embarked on its global expansion strategy three years ago with its entry into Thailand and has established a presence across key international markets, including distribution in Europe, Japan, and Australia.
Through New Garden Pharma's EU-GMP facility in Skopje, North Macedonia, Sunderstorm will produce pharmaceutical‑grade cannabis edibles tailored for distribution across Europe and Australia, while also collaborating on the commercialization of premium cannabis flower and the joint development of innovative new product formats. The partnership provides the infrastructure, regulatory compliance, and manufacturing excellence required to meet the rigorous demands of global medical cannabis markets.
Europe and Asia-Pacific represent some of the fastest-growing medical cannabis markets in the world. Europe's medical market, valued at approximately US $3 billion in 2025, is projected to surge to US $13.16 billion by 2034, according to imarc.
Meanwhile, the medical market in the Asia-Pacific region, currently estimated at US $630 million, is expected to expand to US $2.63 billion by 2033, according to Straits Research.
KANHA, one of the largest edible brands in the United States, is recognized globally for its clean, high-quality, fast-acting formulations, precise dosing, and scientifically backed ingredients. The brand launched its global strategy in Thailand in 2023 and Japan in 2025 through its joint venture with Thai Stick Holdings and is now expanding its global footprint to serve Europe and Australia for both wellness and clinical applications.
